MetaCap

Cardio Diagnostics Statistics

NASDAQ: CDIOHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

1.60-0.05 (-3.03%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Cardio Diagnostics by the numbers

Cardio Diagnostics has a market capitalization of $4.7 million based on 2.96M shares outstanding. With trailing EPS of $-2.52, Cardio Diagnostics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.9% below its 50-day average and 22.9% below its 200-day average.

Average daily trading volume is 26.91K shares, or about $43,064 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CDIO valuation vs. peer median

CDIO compared with the median of 8 peer companies
MetricCDIOPeer medianDifference
Market cap$4.74M$5.46M-13%
Avg. volume26.91K195.12K-86%

Peer median across 8 companies: BMRA, TRIB, VNRX, QCLS, VRAX, IMDX, ICCC, NNNN.

Valuation

Price / sales (latest FY)
319.40
EPS (TTM)
$-2.52

Price and trading

Previous close
1.65
Open
1.68
Day range
1.53 – 1.68
52-week range
0.97 – 7.91
Beta
—
Volume
32.03K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
4.74M
Forward Pe
-6.40
Eps
-2.52
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
7.91
Week52 Low
0.97
Avg Volume
26,915.00
Shares Outstanding
2.96M
Ma50
1.82
Ma200
2.07
Earnings Date
Nov 6, 2026
Pct From52w High
-79.77%
Pct From52w Low
64.95%

Related